Uni-Bio Science Group Limited
UNBSF
$0.00
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.41% | 15.53% | 14.47% | 8.62% | 3.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.41% | 15.53% | 14.47% | 8.62% | 3.01% |
| Cost of Revenue | 25.73% | 12.54% | 0.37% | -10.72% | -20.30% |
| Gross Profit | 14.57% | 16.17% | 17.77% | 13.51% | 9.32% |
| SG&A Expenses | 19.72% | 14.14% | 8.62% | 0.86% | -6.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 59.69% | 56.84% | 54.84% | 25.86% | -25.25% |
| Total Operating Expenses | 20.62% | 16.40% | 12.10% | 3.31% | -4.99% |
| Operating Income | 0.94% | 11.83% | 26.31% | 37.07% | 49.05% |
| Income Before Tax | -5.21% | 5.67% | 20.40% | 32.81% | 46.07% |
| Income Tax Expenses | 34.02% | 50.69% | 67.81% | 3.64% | -35.93% |
| Earnings from Continuing Operations | -7.27% | 2.96% | 17.04% | 35.67% | 56.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.27% | 2.96% | 17.04% | 35.67% | 56.60% |
| EBIT | 0.94% | 11.83% | 26.31% | 37.07% | 49.05% |
| EBITDA | -0.18% | 10.18% | 23.86% | 37.67% | 53.60% |
| EPS Basic | 0.00% | 11.76% | 28.57% | 46.15% | 66.67% |
| Normalized Basic EPS | -14.29% | 0.00% | 20.00% | 30.00% | 40.00% |
| EPS Diluted | 0.00% | 11.76% | 28.57% | 46.15% | 66.67% |
| Normalized Diluted EPS | -14.29% | 0.00% | 20.00% | 30.00% | 40.00% |
| Average Basic Shares Outstanding | -3.52% | -3.52% | -3.53% | -2.52% | -1.52% |
| Average Diluted Shares Outstanding | -3.52% | -3.52% | -3.53% | -2.52% | -1.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |